Maximally Safe Resection Followed by Hypofractionated Re-Irradiation for Locally Recurrent Ependymoma in Children

被引:29
作者
Liu, Arthur K. [1 ]
Foreman, Nicholas K. [2 ,3 ]
Gaspar, Laurie E. [1 ]
Trinidad, Elizabeth [4 ]
Handler, Michael H. [3 ,4 ]
机构
[1] Univ Colorado Denver, Dept Radiat Oncol, Aurora, CO 80045 USA
[2] Childrens Hosp, Dept Neurooncol, Aurora, CO USA
[3] Univ Colorado Denver, Dept Neurosurg, Aurora, CO 80045 USA
[4] Childrens Hosp, Dept Neurosurg, Aurora, CO USA
关键词
ependymoma; hypofractionated re-irradiation; pediatric; recurrent; FRACTIONATED STEREOTACTIC RADIOTHERAPY; I DOSE-ESCALATION; PROGNOSTIC-FACTORS; INTRACRANIAL EPENDYMOMA; PHASE-II; MALIGNANT GLIOMAS; RADIATION-THERAPY; SALVAGE THERAPY; ORAL ETOPOSIDE; CANCER GROUP;
D O I
10.1002/pbc.21982
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Treatment failure in children with ependymoma is relatively common, with the majority of events consisting of local failure. Salvage therapy for these children historically had poor results, with repeated local recurrences. To improve these outcomes, we began to offer hypofractionated re-irradiation after resection at first local recurrence. To minimize the duration of therapy, we chose a hypofractionated regimen that has been shown to be well tolerated in adult patients. Procedure. We performed a review of the experience at the Children's Hospital in Denver and at the Department of Radiation Oncology at the University of Colorado Denver from 1995 to 2008 with hypofractionated re-irradiation after maximally safe resection in children with locally recurrent ependymoma. Results. Six children with locally recurrent ependymoma were seen in that time period. After maximally safe resection, all six received hypofractionated radiation therapy of 24-30 Gy delivered in three fractions. With a median follow-up of 28 months from the time of re-irradiation, all six children are alive with no evidence of disease. Three children had evidence of radiation necrosis, either clinically or based on imaging, but none required significant intervention. Conclusions. Hypofractionated re-irradiation after resection for locally recurrent ependymoma is well tolerated. This approach also appears to provide good local control. Additional follow-up is required to determine the efficacy and potential late effects of hypofractionated re-irradiation in this patient population. Pediatr Blood Cancer 2009;52:804-807. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:804 / 807
页数:4
相关论文
共 28 条
  • [1] Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
    Brandsma, Dieto
    Stalpers, Lukas
    Taal, Walter
    Sminia, Peter
    van den Bent, Martinj
    [J]. LANCET ONCOLOGY, 2008, 9 (05) : 453 - 461
  • [2] Recurrent intracranial ependymoma in children: Salvage therapy with oral etoposide
    Chamberlain, MC
    [J]. PEDIATRIC NEUROLOGY, 2001, 24 (02) : 117 - 121
  • [3] INTRACRANIAL EPENDYMOMA IN CHILDREN - ANALYSIS OF PROGNOSTIC FACTORS
    CHIU, JK
    WOO, SY
    ATER, J
    CONNELLY, J
    BRUNER, JM
    MAOR, MH
    VANEYS, J
    OSWALD, MJ
    SHALLENBERGER, R
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1992, 13 (03) : 283 - 290
  • [4] Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas
    Cho, KH
    Hall, WA
    Gerbi, BJ
    Higgins, PD
    McGuire, WA
    Clark, HB
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (05): : 1133 - 1141
  • [5] Local radiotherapeutic management of ependymomas with fractionated stereotactic radiotherapy (FSRT)
    Combs, Stephanie E.
    Thilmann, Christoph
    Debus, Juergen
    Schulz-Ertner, Daniela
    [J]. BMC CANCER, 2006, 6 (1)
  • [6] Intracranial ependymomas: Analysis of prognostic factors in a population-based series
    Foreman, NK
    Love, S
    Thorne, R
    [J]. PEDIATRIC NEUROSURGERY, 1996, 24 (03) : 119 - 125
  • [7] Fractionated stereotactic radiotherapy with cis-platinum radiosensitization in the treatment of recurrent, progressive, or persistent malignant astrocytoma
    Glass, J
    Silverman, CL
    Axelrod, R
    Corn, BW
    Andrews, DW
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (03): : 226 - 229
  • [8] GOLDWEIN JW, 1990, CANCER-AM CANCER SOC, V66, P557, DOI 10.1002/1097-0142(19900801)66:3<557::AID-CNCR2820660325>3.0.CO
  • [9] 2-8
  • [10] Grill J, 1996, PEDIATR NEUROSURG, V25, P7